Hypoxia-induced DNA hypermethylation: another reason to normalize tumor vessels
暂无分享,去创建一个
[1] S. Chanock,et al. TET2 binds the androgen receptor and loss is associated with prostate cancer , 2016, Oncogene.
[2] R. Jain,et al. Hypoxia-induced DNA hypermethylation: another reason to normalize tumor vessels , 2016 .
[3] Dai Fukumura,et al. Reengineering the Tumor Microenvironment to Alleviate Hypoxia and Overcome Cancer Heterogeneity. , 2016, Cold Spring Harbor perspectives in medicine.
[4] K. Wellen,et al. Metabolic control of epigenetics in cancer , 2016, Nature Reviews Cancer.
[5] D. Lambrechts,et al. TET enzymes as oxygen-dependent tumor suppressors: exciting new avenues for cancer management. , 2016, Epigenomics.
[6] M. Simon,et al. Oxygen availability and metabolic adaptations , 2016, Nature Reviews Cancer.
[7] Peter A. Jones,et al. Targeting the cancer epigenome for therapy , 2016, Nature Reviews Genetics.
[8] Bram Boeckx,et al. Tumor hypoxia causes DNA hypermethylation by reducing TET activity , 2016, Nature.
[9] Shawn M. Gillespie,et al. Insulator dysfunction and oncogene activation in IDH mutant gliomas , 2015, Nature.
[10] W. Kaelin,et al. Fumarate and Succinate Regulate Expression of Hypoxia-inducible Genes via TET Enzymes* , 2015, The Journal of Biological Chemistry.
[11] E. Roussakis,et al. Oxygen-Sensing Methods in Biomedicine from the Macroscale to the Microscale. , 2015, Angewandte Chemie.
[12] R. Jain,et al. Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia. , 2014, Cancer cell.
[13] G. Semenza,et al. Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology. , 2014, Annual review of pathology.
[14] Rakesh K. Jain,et al. Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels , 2013, Nature Communications.
[15] T. Mak,et al. Oncogenic isocitrate dehydrogenase mutations: mechanisms, models, and clinical opportunities. , 2013, Cancer discovery.
[16] Swati Kadam,et al. 5-hydroxymethylcytosine and its potential roles in development and cancer , 2013, Epigenetics & Chromatin.
[17] P. Ratcliffe. Oxygen sensing and hypoxia signalling pathways in animals: the implications of physiology for cancer , 2013, The Journal of physiology.
[18] Bruce R. Rosen,et al. Vessel Architectural Imaging Identifies Cancer Patient Responders to Anti-angiogenic Therapy , 2013, Nature Medicine.
[19] Triantafyllos Stylianopoulos,et al. Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors , 2012, Proceedings of the National Academy of Sciences.
[20] W. Wilson,et al. Targeting hypoxia in cancer therapy , 2011, Nature Reviews Cancer.
[21] M. Esteller,et al. Cancer epigenetics reaches mainstream oncology , 2011, Nature Medicine.
[22] B. Wouters,et al. Hypoxia signalling through mTOR and the unfolded protein response in cancer , 2008, Nature Reviews Cancer.
[23] Richard P. Hill,et al. Hypoxia and metabolism: Hypoxia, DNA repair and genetic instability , 2008, Nature Reviews Cancer.
[24] R. Jain. Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy , 2005, Science.
[25] Rakesh K. Jain,et al. Interstitial pH and pO2 gradients in solid tumors in vivo: High-resolution measurements reveal a lack of correlation , 1997, Nature Medicine.